Health
Nanotechnology offers new hope for bowel cancer patients – Newswise
Bowel cancer is the second deadliest cancer in the world, killing almost 900,000 people in 2020. New research from Indian and Australian scientists suggests tha
Newswise — Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment.
That’s the finding from Indian and Australian scientists who have undertaken the first study, using nanoparticles to target bowel cancer, the third most common cancer in the world and the second most deadliest.
The researchers have shown in animal experiments that nanoparticles containing the chemotherapy drug Capecitabine (CAP) attach…
-
Noosa News23 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General22 hours agoBudget blowout ‘modest’ for Australia’s Olympic hosts
-
Business23 hours agoWant passive income? These ASX dividend stocks could help
-
Business23 hours agoRio Tinto milestone sends shares in resources tech stock higher